Latest From Reed Miller
In an interview with Medtech Insight, Biotronik president Ryan Walters explained why the former Mayo Clinic cardiologist was the right choice to be the first CMO in the company's history and David Hayes discussed his reasons for taking the job.
Device Week, 17 May 2020 – COVID-19 Impact On Q1 2020 Earnings In Orthopedics; Highlights From HRS 2020
In this week’s podcast, Medtech Insight's Reed Miller highlights trial results from Boston Scientific and Medtronic at HRS 2020, and Marion Webb discusses the impact of COVID-19 on Q1 2020 earnings results of major orthopedics companies.
The PINNACLE FLX trial of the next-generation WATCHMAN left atrial appendage closure device met its primary safety and effectiveness endpoints with a low adverse event rate of 0.5%.
The BlueSync Evaluation study showed pacemaker patients using the MyCareLink Heart mobile device app were able to stick to their prescribed transmission schedule more often than patients using beside consoles.
The Micra CED study showed a lower rate of complications with the Micra leadless pacemaker than transvenous single-chamber pacemakers.
Results of two studies presented at the Heart Rhythm Society Scientific Sessions support the subcutaneous implantable cardioverter defibrillator as an alternative to ICDs with transvenous leads.